ALMKT Stock Overview
A medical device company, manufactures and sells medical devices in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Mauna Kea Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.26 |
| 52 Week High | €0.53 |
| 52 Week Low | €0.26 |
| Beta | 1.28 |
| 11 Month Change | -22.32% |
| 3 Month Change | -29.93% |
| 1 Year Change | -39.51% |
| 33 Year Change | -71.32% |
| 5 Year Change | -71.41% |
| Change since IPO | -97.97% |
Recent News & Updates
Recent updates
What Mauna Kea Technologies SA's (EPA:ALMKT) 31% Share Price Gain Is Not Telling You
Jul 23
Mauna Kea Technologies SA's (EPA:ALMKT) Share Price Could Signal Some Risk
Mar 23What Is Mauna Kea Technologies SA's (EPA:MKEA) Share Price Doing?
Jan 12Mauna Kea Technologies (EPA:MKEA) Share Prices Have Dropped 70% In The Last Three Years
Nov 26Shareholder Returns
| ALMKT | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | -0.4% | 5.0% | 1.2% |
| 1Y | -39.5% | 27.2% | 0.8% |
Return vs Industry: ALMKT underperformed the French Medical Equipment industry which returned 27.1% over the past year.
Return vs Market: ALMKT underperformed the French Market which returned 0.7% over the past year.
Price Volatility
| ALMKT volatility | |
|---|---|
| ALMKT Average Weekly Movement | 7.4% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.5% |
| 10% least volatile stocks in FR Market | 2.1% |
Stable Share Price: ALMKT's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALMKT's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 65 | Sacha Loiseau | www.maunakeatech.com |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
Mauna Kea Technologies SA Fundamentals Summary
| ALMKT fundamental statistics | |
|---|---|
| Market cap | €16.86m |
| Earnings (TTM) | -€11.21m |
| Revenue (TTM) | €8.16m |
2.1x
P/S Ratio-1.5x
P/E RatioIs ALMKT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALMKT income statement (TTM) | |
|---|---|
| Revenue | €8.16m |
| Cost of Revenue | €2.25m |
| Gross Profit | €5.91m |
| Other Expenses | €17.12m |
| Earnings | -€11.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 72.42% |
| Net Profit Margin | -137.49% |
| Debt/Equity Ratio | -137.6% |
How did ALMKT perform over the long term?
See historical performance and comparison